Developing better methods to create carbohydrates and glycoconjugates for health applications
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
This study is working on better ways to create important sugars and sugar-related compounds that can help improve treatments for various health conditions, making them more effective for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11001454 on NIH RePORTER |
What this research studies
This research focuses on improving the chemical synthesis of carbohydrates and glycoconjugates, which are essential for many biological processes. The team aims to develop efficient methods to selectively modify hydroxyl groups in carbohydrates, addressing challenges in their synthesis. By enhancing the ability to functionalize and remove protective groups in carbohydrates, the research seeks to create more effective therapeutic agents. Patients may benefit from advancements in treatments that rely on these complex molecules.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated with carbohydrate-based therapies.
Not a fit: Patients with conditions unrelated to carbohydrate metabolism or those not requiring carbohydrate-based treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for various diseases by enhancing the development of carbohydrate-based treatments.
How similar studies have performed: Other research has shown success in developing chemical methods for carbohydrate synthesis, indicating a promising avenue for therapeutic advancements.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Tang, Weiping — University of Wisconsin-Madison
- Study coordinator: Tang, Weiping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.